Tafasitamab, CAS 1422527-84-1

Product Description: Tafasitamab (XmAb5574) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigenCD19[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Jung Hyun Her, et al. Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapy. Cancer Immunol Immunother. 2022 Mar 29./[2]Holly M Horton, et al. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia. Cancer Res

CAS Number: 1422527-84-1

Molecular Weight: N/A

Compound Purity: 98.53

Research Area: Cancer; Inflammation/Immunology

Solubility: H2O

Target: Apoptosis

• SKU: MEXHY-P9981-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P9981-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated